Changing roles of population-based cancer registries in Australia

Roder, D; Creighton, N; Baker, D; Walton, R; Aranda, S; Currow, D

Changing roles of population-based cancer registries in Australia

Roder, D Creighton, N Baker, D Walton, R Aranda, S

Currow, D

Permalink

Publication Type:: Journal Article
Citation:: Australian Health Review, 2015, 39 (4), pp. 425 - 428
Issue Date:: 2015-01-01

Closed Access

	Filename	Description	Size
	AH14250.pdf	Published Version	205.92 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Roder, D	en_US
dc.contributor.author	Creighton, N	en_US
dc.contributor.author	Baker, D	en_US
dc.contributor.author	Walton, R	en_US
dc.contributor.author	Aranda, S https://orcid.org/0000-0003-4170-9799	en_US
dc.contributor.author	Currow, D https://orcid.org/0000-0003-1988-1250	en_US
dc.date.available	2015-02-04	en_US
dc.date.issued	2015-01-01	en_US
dc.identifier.citation	Australian Health Review, 2015, 39 (4), pp. 425 - 428	en_US
dc.identifier.issn	0156-5788	en_US
dc.identifier.uri	http://hdl.handle.net/10453/118405
dc.description.abstract	© AHHA 2015. Registries have key roles in cancer incidence, mortality and survival monitoring and in showing disparities across the population. Incidence monitoring began in New South Wales in 1972 and other jurisdictions soon followed. Registry data are used to evaluate outcomes of preventive, screening, treatment and support services. They have shown decreases in cancer incidence following interventions and have been used for workforce and other infrastructure planning. Crude markers of optimal radiotherapy and chemotherapy exist and registry data are used to show shortfalls against these markers. The data are also used to investigate cancer clusters and environmental concerns. Survival data are used to assess service performance and interval cancer data are used in screening accreditation. Registries enable determination of risk of multiple primary cancers. Clinical quality registries are used for clinical quality improvement. Population-based cancer registries and linked administrative data complement clinical registries by providing high-level system-wide data. The USA Commission on Cancer has long used registries for quality assurance and service accreditation. Increasingly population-based registry data in Australia are linked with administrative data on service delivery to assess system performance. Addition of tumour stage and other prognostic indicators is important for these analyses and is facilitated by the roll-out of structured pathology reporting. Data linkage with administrative data, following checks on the quality of these data, enables assessment of patterns of care and other performance indicators for health-system monitoring. Australian cancer registries have evolved and increasingly are contributing to broader information networks for health system management.	en_US
dc.relation.ispartof	Australian Health Review	en_US
dc.relation.isbasedon	10.1071/AH14250	en_US
dc.subject.classification	Health Policy & Services	en_US
dc.subject.mesh	Humans	en_US
dc.subject.mesh	Neoplasms	en_US
dc.subject.mesh	Registries	en_US
dc.subject.mesh	Incidence	en_US
dc.subject.mesh	Survival Analysis	en_US
dc.subject.mesh	Health Services Research	en_US
dc.subject.mesh	Australia	en_US
dc.title	Changing roles of population-based cancer registries in Australia	en_US
dc.type	Journal Article
utslib.citation.volume	4	en_US
utslib.citation.volume	39	en_US
utslib.for	1110 Nursing	en_US
utslib.for	1117 Public Health and Health Services	en_US
utslib.for	1605 Policy and Administration	en_US
pubs.embargo.period	Not known	en_US
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
pubs.organisational-group	/University of Technology Sydney/Faculty of Health/IMPACCT
utslib.copyright.status	closed_access
pubs.issue	4	en_US
pubs.publication-status	Published	en_US
pubs.volume	39	en_US

Abstract:

© AHHA 2015. Registries have key roles in cancer incidence, mortality and survival monitoring and in showing disparities across the population. Incidence monitoring began in New South Wales in 1972 and other jurisdictions soon followed. Registry data are used to evaluate outcomes of preventive, screening, treatment and support services. They have shown decreases in cancer incidence following interventions and have been used for workforce and other infrastructure planning. Crude markers of optimal radiotherapy and chemotherapy exist and registry data are used to show shortfalls against these markers. The data are also used to investigate cancer clusters and environmental concerns. Survival data are used to assess service performance and interval cancer data are used in screening accreditation. Registries enable determination of risk of multiple primary cancers. Clinical quality registries are used for clinical quality improvement. Population-based cancer registries and linked administrative data complement clinical registries by providing high-level system-wide data. The USA Commission on Cancer has long used registries for quality assurance and service accreditation. Increasingly population-based registry data in Australia are linked with administrative data on service delivery to assess system performance. Addition of tumour stage and other prognostic indicators is important for these analyses and is facilitated by the roll-out of structured pathology reporting. Data linkage with administrative data, following checks on the quality of these data, enables assessment of patterns of care and other performance indicators for health-system monitoring. Australian cancer registries have evolved and increasingly are contributing to broader information networks for health system management.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/118405